These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16000704)

  • 1. Phage therapy: the Escherichia coli experience.
    Brüssow H
    Microbiology (Reading); 2005 Jul; 151(Pt 7):2133-2140. PubMed ID: 16000704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scoping the effectiveness and evolutionary obstacles in using plasmid-dependent phages to fight antibiotic resistance.
    Ojala V; Mattila S; Hoikkala V; Bamford JKh; Hiltunen T; Jalasvuori M
    Future Microbiol; 2016 Aug; 11():999-1009. PubMed ID: 27503765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficiency of using Salmonella Kentucky and Escherichia coli O119 bacteriophages in the treatment and prevention of salmonellosis and colibacillosis in broiler chickens.
    Sorour HK; Gaber AF; Hosny RA
    Lett Appl Microbiol; 2020 Oct; 71(4):345-350. PubMed ID: 32628287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a broad host range lytic bacteriophage against E. coli adhered to urothelium.
    Sillankorva S; Oliveira D; Moura A; Henriques M; Faustino A; Nicolau A; Azeredo J
    Curr Microbiol; 2011 Apr; 62(4):1128-32. PubMed ID: 21140149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.
    Cieplak T; Soffer N; Sulakvelidze A; Nielsen DS
    Gut Microbes; 2018; 9(5):391-399. PubMed ID: 29517960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage therapy targeting Escherichia coli-a story with no end?
    Bolocan AS; Callanan J; Forde A; Ross P; Hill C
    FEMS Microbiol Lett; 2016 Nov; 363(22):. PubMed ID: 27974392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of Escherichia coli-bacteriophage interactions by surfactants and antibiotics in vitro.
    Scanlan PD; Bischofberger AM; Hall AR
    FEMS Microbiol Ecol; 2017 Jan; 93(1):. PubMed ID: 27737900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli.
    Yu L; Wang S; Guo Z; Liu H; Sun D; Yan G; Hu D; Du C; Feng X; Han W; Gu J; Sun C; Lei L
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):971-983. PubMed ID: 29150707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage therapy gets revitalized.
    Reardon S
    Nature; 2014 Jun; 510(7503):15-6. PubMed ID: 24899282
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing urinary tract infections through phage therapy: a novel approach.
    Malik S; Sidhu PK; Rana JS; Nehra K
    Folia Microbiol (Praha); 2020 Apr; 65(2):217-231. PubMed ID: 31494814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a Chicken Embryo Lethality Assay to Assess the Efficacy of Phage Therapy.
    Trotereau A; Schouler C
    Methods Mol Biol; 2019; 1898():199-205. PubMed ID: 30570735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of stx2 converting bacteriophages induced from Shiga-toxin-producing Escherichia coli strains isolated from cattle.
    Muniesa M; Blanco JE; de Simón M; Serra-Moreno R; Blanch AR; Jofre J
    Microbiology (Reading); 2004 Sep; 150(Pt 9):2959-2971. PubMed ID: 15347754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Escherichia coli isolated from uteri of postpartum dairy cows to antibiotic and environmental bacteriophages. Part II: In vitro antimicrobial activity evaluation of a bacteriophage cocktail and several antibiotics.
    Santos TM; Gilbert RO; Caixeta LS; Machado VS; Teixeira LM; Bicalho RC
    J Dairy Sci; 2010 Jan; 93(1):105-14. PubMed ID: 20059909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T4-like Escherichia coli phages from the environment carry bla
    Mohan Raj JR; Vittal R; Huilgol P; Bhat U; Karunasagar I
    Lett Appl Microbiol; 2018 Jul; 67(1):9-14. PubMed ID: 29675838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.
    Matsuda T; Freeman TA; Hilbert DW; Duff M; Fuortes M; Stapleton PP; Daly JM
    Surgery; 2005 Jun; 137(6):639-46. PubMed ID: 15933632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "My enemy's enemy is my friend." Using phages to fight bacteria.
    Bradbury J
    Lancet; 2004 Feb; 363(9409):624-5. PubMed ID: 14989277
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of a combination of bacteriophages and antimicrobial plant extracts.
    Pimchan T; Cooper CJ; Eumkeb G; Nilsson AS
    Lett Appl Microbiol; 2018 Mar; 66(3):182-187. PubMed ID: 29266343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Escherichia coli isolated from uteri of postpartum dairy cows to antibiotic and environmental bacteriophages. Part I: Isolation and lytic activity estimation of bacteriophages.
    Bicalho RC; Santos TM; Gilbert RO; Caixeta LS; Teixeira LM; Bicalho ML; Machado VS
    J Dairy Sci; 2010 Jan; 93(1):93-104. PubMed ID: 20059908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.